K Number
K221753
Device Name
Kangbeier Child Surgical Mask
Date Cleared
2023-12-21

(553 days)

Product Code
Regulation Number
878.4040
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Kangbeier Child Surgical Mask is intended to be worn by the patient (ages 5-10) to cover the nose and mouth to provide a barrier for the respiratory tract for microorganisms and particulate materials. The Kangbeier Child Surgical Mask is a single use, disposable device, provided non-sterile. This Face Mask is recommended for use in a healthcare setting with appropriate adult supervision.
Device Description
The Kangbeier Child Surgical Mask is composed of three layers of materials and pleated to form the mask. The inner layer is composed of spun-bond nonwoven polypropylene, the middle layer is meltblown polypropylene filter material, and the outer layer is spunbond nonwoven polypropylenen. The color on the outer layer is consists of Phthalocyanine Blue and PE wax and PP. Masks are held in place on wearer with elastic spun-bond polypropylene earloop and contain a malleable aluminum nosepiece strip. The Kangbeier Child Surgical Mask is appropriately sized to the smaller faces of children across a diverse population. The Kangbeier Child Surgical Mask is a single use, disposable device, provided nonsterile with no shelf-life. Storage conditions will not affect device safety of effectiveness. All of the materials used in this device are typical materials commonly used in the construction of Surgical Masks and are being used in current legally marketed devices.
More Information

Not Found

No
The device description and performance metrics relate to the physical properties and filtration capabilities of a surgical mask, with no mention of software, algorithms, or data processing that would indicate AI/ML.

No
The device is a surgical mask intended to be a barrier for microorganisms and particulate materials, not to treat or cure a disease or condition.

No
The device is a surgical mask intended to provide a physical barrier for the respiratory tract, not to diagnose any condition.

No

The device description clearly outlines physical components (three layers of materials, earloops, nosepiece) and performance metrics related to filtration and physical properties, indicating it is a physical medical device, not software-only.

Based on the provided information, the Kangbeier Child Surgical Mask is not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use is to provide a physical barrier for the respiratory tract against microorganisms and particulate materials. This is a protective function, not a diagnostic one.
  • Device Description: The description focuses on the physical construction and materials of the mask. There is no mention of components designed to analyze biological samples or provide diagnostic information.
  • Performance Studies and Key Metrics: The performance studies and metrics (filtration efficiency, differential pressure, flammability, synthetic blood penetration) are all related to the physical barrier and protective capabilities of the mask. They do not involve the analysis of biological samples for diagnostic purposes.
  • Lack of IVD Characteristics: There is no mention of reagents, assays, or any other elements typically associated with in vitro diagnostic devices.

In summary, the Kangbeier Child Surgical Mask is a personal protective equipment (PPE) device designed to prevent the transmission of particles and microorganisms, not to diagnose a condition.

N/A

Intended Use / Indications for Use

The Kangbeier Child Surgical Mask is intended to be worn by the patient (ages 5-10) to cover the nose and mouth to provide a barrier for the respiratory tract for microorganisms and particulate materials. The Kangbeier Child Surgical Mask is a single use, disposable device, provided non-sterile. This Face Mask is recommended for use in a healthcare setting with appropriate adult supervision.

Product codes

OXZ

Device Description

The Kangbeier Child Surgical Mask is composed of three layers of materials and pleated to form the mask. The inner layer is composed of spun-bond nonwoven polypropylene, the middle layer is meltblown polypropylene filter material, and the outer layer is spunbond nonwoven polypropylenen. The color on the outer layer is consists of Phthalocyanine Blue and PE wax and PP. Masks are held in place on wearer with elastic spun-bond polypropylene earloop and contain a malleable aluminum nosepiece strip.

The Kangbeier Child Surgical Mask is appropriately sized to the smaller faces of children across a diverse population.

The Kangbeier Child Surgical Mask is a single use, disposable device, provided nonsterile with no shelf-life. Storage conditions will not affect device safety of effectiveness. All of the materials used in this device are typical materials commonly used in the construction of Surgical Masks and are being used in current legally marketed devices.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Nose and mouth

Indicated Patient Age Range

ages 5-10

Intended User / Care Setting

Healthcare setting with appropriate adult supervision.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

To prove the safety and effectiveness of the Kangbeier Child Surgical Mask , we tested the device according to corresponding standards. Those tests include performance tests and biocompatibility tests.

The Kangbeier Child Surgical Mask has been tested under the following standards:
ASTM F2100-20 Standard Specification for Performance of Materials Used in Medical Face Masks
ASTM F1862-17 Standard Test Method for Resistance of Surgical Mask to Penetration by Synthetic Blood
ASTM F2299(2017) Test Method for Determining the Initial Efficiency of Materials Used in Medical Face Masks to Penetration by Particulates Using Latex Spheres
ASTM F2101-19 Standard Test Method for Evaluating the Bacterial Filtration Efficiency (BFE) of surgical masks using a Biological Aerosol of Staphylococcus aureus
16 CFR Part 1610 Standard for the flammability of clothing textiles
EN 14683:2019,Annex C Medical Fask Masks-Requirements and Test Methods
CPSC-CH-E1002-08 Total Lead Content Analysis
CPSC-CH-E1001-09.4 Standart Operating Procedure for Determination of Phthalates
EN71-3:2019 Safety of Toys-Migration of certain 19 elements
ISO 10993-1, Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process
ISO 10993-5:2009,Biological evaluation of medical devices —Part 5:Tests for in vitro cytotoxicity
ISO 10993-10:2010,Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization

Key Metrics

Particulate Filtration Efficiency at 0.1 microns: >=98%
Bacterial Filtration: >=98%
Differential Pressure (Delta P, mm H2O/cm2): =160 mmHg

Predicate Device(s)

K160100

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4040 Surgical apparel.

(a)
Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.(b)
Classification. (1) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption:(i) The user contacting components of the device must be demonstrated to be biocompatible.
(ii) Analysis and nonclinical testing must:
(A) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
(B) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
(iii) NIOSH approved under its regulation.
(2) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.

0

December 21, 2023

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA acronym is in a blue square, and the full name "U.S. Food & Drug Administration" is in blue text.

Xinxiang Kangbeier Medical Technology Co., Ltd. Shaoju Tian East Mancun Industrial District Changyuan, Henan 453400 China

Re: K221753

Trade/Device Name: Kangbeier Child Surgical Mask Regulation Number: 21 CFR 878.4040 Regulation Name: Surgical Apparel Regulatory Class: Class II Product Code: OXZ Dated: December 6, 2023 Received: December 6, 2023

Dear Shaoju Tian:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

1

2

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.70) and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Katherine D. Kavlock -S

for

Brent Showalter, Ph.D. Assistant Director DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

2

Indications for Use

510(k) Number (if known) K221753

Device Name Kangbeier Child Surgical Mask

Indications for Use (Describe)

The Kangbeier Child Surgical Mask is intended to be worn by the patient (ages 5-10) to cover the nose and mouth to provide a barrier for the respiratory tract for microorganisms and particulate materials. The Kangbeier Child Surgical Mask is a single use, disposable device, provided non-sterile. This Face Mask is recommended for use in a healthcare setting with appropriate adult supervision.

Type of Use (Select one or both, as applicable)
-------------------------------------------------
Research Use (Part 21 CFR 361. Subject to Phase 1)Same Tier Comparator (21 CFR 361. Subject to Phase 1)
---------------------------------------------------------------------------------------------------------------------------------------

__ Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Section 5: 510(k) Summary:

This summary of 510k safety and effectiveness information is being submitted In accordance with the requirements of 21CFR 807.92

5.1 Submitter & Foreign Manufacture Identification

Xinxiang Kangbeier Medical Technology Co., Ltd. East Mancun Industrial District, Changyuan, Henan 453400 , China Tel: 13341254319 Submitter's FDA Registration Number: N/A

5.2 Contact Person

Name: Shaoju Tian Company: Blue Land Michigan Inc. Address: 5830 E 2nd St Ste 8 Casper, WY 82609 USA Tel: 86 13341254319 Email: technology@med-bridges.com

5.3 Date of Summary: December 6, 2023

5.4Device Name:
---------------------
Proprietary Name:Kangbeier Child Surgical Mask
Common Name:Child Surgical Mask
Classification Name:Pediatric/Child Facemask
Device Classification:II
Regulation Number:21 CFR 878.4040
Panel:General Hospital
Product Code:OXZ

ર.5 Predicate Device Information:

  • K160100, "Prestige Ameritech Pediatric/Child's Face Mask", (1) manufactured by "Prestige Ameritech"

5.6 Device Description:

The Kangbeier Child Surgical Mask is composed of three layers of materials and pleated to form the mask. The inner layer is composed of spun-bond nonwoven polypropylene, the middle layer is meltblown polypropylene filter material, and the outer layer is spunbond nonwoven polypropylenen. The color on the outer layer is consists of Phthalocyanine Blue and PE wax and PP. Masks are held in place on wearer with elastic spun-bond polypropylene earloop and contain a malleable aluminum nosepiece strip.

The Kangbeier Child Surgical Mask is appropriately sized to the smaller faces of

4

children across a diverse population.

The Kangbeier Child Surgical Mask is a single use, disposable device, provided nonsterile with no shelf-life. Storage conditions will not affect device safety of effectiveness. All of the materials used in this device are typical materials commonly used in the construction of Surgical Masks and are being used in current legally marketed devices..

5.7 Indications for Use:

The Kangbeier Child Surgical Mask is intended to be worn by the patient (ages 5-10) to cover the nose and mouth to provide a barrier for the respiratory tract for microorganisms and particulate materials. The Kangbeier Child Surgical Mask is a single use, disposable device, provided non-sterile. This Face Mask is recommended for use in a healthcare setting with appropriate adult supervision.

5.8 Testing Summary:

To prove the safety and effectiveness of the Kangbeier Child Surgical Mask , we tested the device according to corresponding standards. Those tests include performance tests and biocompatibility tests.

The Kangbeier Child Surgical Mask has been tested under the following standards:

ASTM F2100-20 Standard Specification for Performance of Materials Used in Medical Face Masks

ASTM F1862-17 Standard Test Method for Resistance of Surgical Mask to Penetration by Synthetic Blood

ASTM F2299(2017) Test Method for Determining the Initial Efficiency of Materials Used in Medical Face Masks to Penetration by Particulates Using Latex Spheres

ASTM F2101-19 Standard Test Method for Evaluating the Bacterial Filtration

Efficiency (BFE) of surgical masks using a Biological Aerosol of Staphylococcus aureus 16 CFR Part 1610 Standard for the flammability of clothing textiles

EN 14683:2019,Annex C Medical Fask Masks-Requirements and Test Methods CPSC-CH-E1002-08 Total Lead Content Analysis

CPSC-CH-E1001-09.4 Standart Operating Procedure for Determination of Phthalates EN71-3:2019 Safety of Toys-Migration of certain 19 elements

ISO 10993-1, Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

ISO 10993-5:2009,Biological evaluation of medical devices —Part 5:Tests for in vitro cytotoxicity

ISO 10993-10:2010,Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization

5

5.9 Comparison with Predicate Device

The following table shows similarities and differences between our device and the predicate devices.

Table 5.1: Comparison

CharacteristicSubject DeviceK160100 (Predicate)Comparison
Particulate Filtration
Efficiency at 0.1 microns≥98%≥98%Same
Bacterial Filtration≥98%96.32%Similar
(Subject
Device better
than Predicate
Device )
Differential Pressure(Delta P, mm
H2O/cm2)